Stool markers for colorectal cancer screening: Future considerations

被引：12

作者：

Ahlquist, DA

Gilbert, JA

机构：

[1] Division of Gastroenterology, Mayo Clinic, Rochester, MN

来源：

DIGESTIVE DISEASES | 1996年 / 14卷 / 03期

关键词：

colorectal cancer screening; stool testing;

D O I：

10.1159/000171545

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Stool screening for colorectal neoplasia has the important advantages of noninvasiveness and affordability over other available screening approaches. However, better markers are needed to improve the sensitivity and specificity of stool screening. A functional classification of stool markers is proposed, based on the mode of luminal marker entry, which may be useful in considering alternative markers.

引用

页码：132 / 144

页数：13

共 81 条

[11] BOLAND CR, 1991, TXB GASTROENTEROLOGY, P1768
[12] BRINKLEY BR, 1984, PROGR CANC RES THERA, V29, P1
[13] CAMERON AB, 1959, SURG FORUM, V10, P30
[14] LECTIN BINDING PATTERNS IN NORMAL AND NEOPLASTIC COLONIC MUCOSA - A STUDY OF DOLICHOS-BIFLORUS AGGLUTININ, PEANUT AGGLUTININ, AND WHEAT-GERM AGGLUTININ
CAMPO, E
CONDOM, E
PALACIN, A
QUESADA, E
CARDESA, A
[J]. DISEASES OF THE COLON & RECTUM, 1988, 31 (11) : 892 - 899
[15] SENSITIVITY OF GUAIAC-IMPREGNATED CARDS FOR THE DETECTION OF COLORECTAL NEOPLASIA
CROWLEY, ML
FREEMAN, LD
MOTTET, MD
STRONG, RM
SWEENEY, BF
BROWER, RA
SHARMA, SP
ANDERSON, DS
[J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1983, 5 (02) : 127 - 130
[16] CUNNINGHAM J, 1992, CANCER RES, V52, P1974
[17] DISTRIBUTION OF A NEW MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN PERIPHERAL-BLOOD LEUKOCYTES - IMMUNOFLUORESCENCE AND IMMUNOPEROXIDASE STAINING FEATURES IN COMPARISON WITH LYSOZYME AND LACTOFERRIN
DALE, I
BRANDTZAEG, P
FAGERHOL, MK
SCOTT, H
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 84 (01) : 24 - 34
[18] DARMON E, 1991, FRONT GASTR RES, V18, P236
[19] DIANYUAN Z, 1993, CHIN MED J, V106, P739
[20] DUBROW R, 1992, AM J GASTROENTEROL, V87, P854

← 1 2 3 4 5 6 7 8 9 →